Cite
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies.
MLA
Brindisi, Margherita, et al. “Novel Spiroindoline HDAC Inhibitors: Synthesis, Molecular Modelling and Biological Studies.” European Journal of Medicinal Chemistry, vol. 157, Sept. 2018, pp. 127–38. EBSCOhost, https://doi.org/10.1016/j.ejmech.2018.07.069.
APA
Brindisi, M., Senger, J., Cavella, C., Grillo, A., Chemi, G., Gemma, S., Cucinella, D. M., Lamponi, S., Sarno, F., Iside, C., Nebbioso, A., Novellino, E., Shaik, T. B., Romier, C., Herp, D., Jung, M., Butini, S., Campiani, G., Altucci, L., & Brogi, S. (2018). Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies. European Journal of Medicinal Chemistry, 157, 127–138. https://doi.org/10.1016/j.ejmech.2018.07.069
Chicago
Brindisi, Margherita, Johanna Senger, Caterina Cavella, Alessandro Grillo, Giulia Chemi, Sandra Gemma, Dora Mariagrazia Cucinella, et al. 2018. “Novel Spiroindoline HDAC Inhibitors: Synthesis, Molecular Modelling and Biological Studies.” European Journal of Medicinal Chemistry 157 (September): 127–38. doi:10.1016/j.ejmech.2018.07.069.